Cowen Prime Advisors’s AstraZeneca AZN Stock Holding History

Cowen Prime Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.71M	Sell	25,910 -850	-3%	-$125K	1.28%	17
2023 Q1	$3.92M	Buy	26,760 +750	+3%	+$101K	1.57%	17
2022 Q4	$3.53M	Hold	26,010	–	–	1.45%	17
2022 Q3	$2.85M	Buy	26,010 +362	+1%	+$45.9K	1.64%	15
2022 Q2	$3.39M	Sell	25,648 -62	-0.2%	-$8.13K	1.93%	11
2022 Q1	$3.41M	Hold	25,710	–	–	1.44%	16
2021 Q4	$3M	Sell	25,710 -1,500	-6%	-$176K	1.02%	27
2021 Q3	$3.27M	Buy	27,210 +400	+1%	+$46.6K	1.22%	21
2021 Q2	$3.21M	Buy	26,810 +50	+0.2%	+$5.49K	1.17%	22
2021 Q1	$2.66M	Buy	26,760 +125	+0.5%	+$12.6K	1.01%	26
2020 Q4	$2.66M	Buy	26,635 +1,275	+5%	+$135K	1.18%	17
2020 Q3	$2.78M	Sell	25,360 -288	-1%	-$32K	1.35%	20
2020 Q2	$3.39M	Buy	25,648 +188	+0.7%	+$19.4K	1.93%	11
2020 Q1	$2.27M	Buy	+25,460	New	+$2.4M	1.39%	17
2019 Q1	–	Sell	-36,520	Closed	-$2.77M	–	179
2018 Q4	$2.77M	Buy	36,520 +875	+2%	+$68.3K	1.67%	16
2018 Q3	$2.82M	Sell	35,645 -3,700	-9%	-$280K	1.31%	24
2018 Q2	$2.76M	Buy	39,345 +5,625	+17%	+$405K	1.36%	22
2018 Q1	$2.36M	Buy	33,720 +6,960	+26%	+$482K	1.31%	25
2017 Q4	$1.86M	Buy	+26,760	New	+$1.8M	0.9%	35

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cowen Prime Advisors's AZN Position: Q2 2023 in Review

Cowen Prime Advisors reduced its AstraZeneca (AZN) stake by 3.2% in Q2 2023, selling an estimated $125K and leaving 25,910 shares worth $3.71M. The position accounts for 1.28% of the portfolio, ranked #17.

Cowen Prime Advisors first reported a position in AZN in Q4 2017 and has held it in 19 quarters since. The position peaked at $3.92M in Q1 2023. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

Cowen Prime Advisors held 25,910 shares of AstraZeneca worth $3.71M as of Q2 2023.
Cowen Prime Advisors sold 850 AstraZeneca shares in Q2 2023, an estimated $125K.
AstraZeneca made up 1.28% of Cowen Prime Advisors's portfolio in Q2 2023, its #17 holding.
Cowen Prime Advisors first reported a position in AstraZeneca in Q4 2017 and has held it in 19 quarters since.
Cowen Prime Advisors's AstraZeneca position peaked at $3.92M in Q1 2023.
1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.